IMR-687: A Multimodal Mechanism of Action
IMR-687 is a highly selective, potent small molecule inhibitor of PDE9 that has a multimodal MOA that acts primarily on red blood cells and has the potential to act on white blood cells, adhesion mediators and other cell types that are implicated in sickle cell disease.